Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-09-27
2005-09-27
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S216000, C514S230500, C514S235500, C514S253010, C514S253130, C514S300000, C514S305000, C514S318000, C514S337000, C514S338000, C514S339000, C514S340000, C514S341000, C514S343000, C514S346000, C514S352000, C514S354000, C540S575000, C540S582000, C544S074000, C544S130000, C544S360000, C544S365000, C546S122000, C546S133000, C546S137000, C546S194000, C546S276400, C546S276700, C546S279100, C546S291000, C546S292000, C546S207000, C546S298000, C546S308000, C546S309000, C546S323000
Reexamination Certificate
active
06949539
ABSTRACT:
The invention provides compounds of general formula (I) in which m, A, R1and Ar have the meanings defined in the specification; a process for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy.
REFERENCES:
patent: 3464998 (1969-09-01), Krimmel
patent: 3471491 (1969-10-01), Venkatachala et al.
patent: 4751292 (1988-06-01), Fox
patent: 650919 (1964-07-01), None
patent: 1943404 (1970-12-01), None
patent: 0002065 (1979-05-01), None
patent: 0867436 (1998-09-01), None
patent: WO 95/04720 (1995-02-01), None
patent: WO 99/29660 (1999-06-01), None
patent: WO 9929660 (1999-06-01), None
patent: WO 99/29661 (1999-06-01), None
patent: WO 9929661 (1999-06-01), None
patent: WO 00/61569 (2000-10-01), None
patent: WO 03/041707 (2003-05-01), None
patent: WO 03/080579 (2003-10-01), None
Costakis et al., “Synthesis of Some Adamantane Derivatives of 2-Aminobenzothiazoles”,Journal of Medicinal Chemistry14(12):1222-1223 (1971).
Ho et al., “Synthesis of a Peptidomimetic Tricyclic Tetrahydrobenzo[ij] quinoline as a VLA-4 Antagonist”,J. Org. Chem. 65:6743-6748, p. 6745, scheme 5, (27) (2000).
STN International, File REGISTRY, see RN 405068-97-5, 405070-41-9, 405076-22-4, Apr. 14, 2002.
STN International, File REGISTRY, see RN 445032-09-7, Aug. 30, 2002.
STN International, File CHEMCATS, Accession No. 2001:48444, May 14, 2001, NS18552, 2-Quinolinecarboxamide, N-(tricycle[3.3.1.13,7]dec-1-ylmethyl), CAS Registry No. 313688-07-2.
STN International, File REGISTRY, see RN 401622-10-4, Mar. 24, 2002.
Alcaraz Lilian
Furber Mark
AstraZeneca AB
Fish & Richardson P.C.
Raymond Richard L.
LandOfFree
Admantane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Admantane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Admantane derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3383870